Randomized trial of pentoxifylline and vitamin e vs standard follow-up after breast irradiation to prevent breast fibrosis, evaluated by tissue compliance meter

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 3, 2013, Pages 604-608

  Jacobson, Geraldine ^a   Bhatia, Sudershan ^a   Smith, Brian J ^a   Button, Anna M ^a   Bodeker, Kellie ^a   Buatti, John ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2-GROUP; AVERAGE DIFFERENCE; BREAST CANCER; BREAST IRRADIATION; DISEASE FREE SURVIVAL; FOLLOW UP; HIGH-RISK PATIENTS; LOCAL CONTROL; LOCAL RECURRENCE; MIRROR IMAGES; OVERALL SURVIVAL; PENTOXIFYLLINE; POSTIRRADIATION; RADIATION-INDUCED; RANDOMIZED CLINICAL TRIALS; RANDOMIZED TRIAL; T-TESTS; VITAMIN-E;

DERMATITIS; IRRADIATION; PATIENT MONITORING; RADIOTHERAPY; TISSUE;

REGULATORY COMPLIANCE;

PENTOXIFYLLINE; VITAMIN;

ADULT; ARTICLE; BREAST CANCER; BREAST FIBROSIS; BREAST IRRADIATION; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; IRRADIATION; MAJOR CLINICAL STUDY; MEASUREMENT; OVERALL SURVIVAL; PARTIAL BODY RADIATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION INDUCED FIBROSIS; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; COMPLIANCE; DRUG THERAPY, COMBINATION; FEMALE; FIBROSIS; HUMANS; MIDDLE AGED; PENTOXIFYLLINE; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; VITAMIN E;

EID: 84873320445     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.06.042     Document Type: Article

References (17)

1. R. Siegel, E. Ward, and O. Brawley Cancer statistics, 2011 CA Cancer J Clin 61 2011 212 236
2. S. Delanian, R. Porcher, and S. Balla-Mekias Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis J Clin Oncol 21 2003 2545 2550
3. A.G. Wernicke, B. Parashar, and F. Kulidzhanov Prospective study validating inter- and intraobserver variability of tissue compliance meter in breast tissue of healthy volunteers: potential implications for patients with radiation-induced fibrosis of the breast Int J Radiat Oncol Biol Phys 80 2011 39 46
4. J. Marinus, C.G. Niel, and R.A. de Bie Measuring radiation fibrosis: the interobserver reliability of two methods of determining the degree of radiation fibrosis Int J Radiat Oncol Biol Phys 47 2000 1209 1217
5. J.J. Pavy, J. Denekamp, J. Letschert EORTC Late Effects Working Group Late effects toxicity scoring: the SOMA scale Int J Radiat Oncol Biol Phys 31 1995 1043 1047
6. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
7. A.A. Fischer Tissue compliance meter for objective, quantitative documentation of soft tissue consistency and pathology Arch Phys Med Rehabil 68 1987 122 125
8. M.W. Dion, D.H. Hussey, and J.W. Osborne The effect of pentoxifylline on early and late radiation injury following fractionated irradiation in C3H mice Int J Radiat Oncol Biol Phys 17 1989 101 107
9. J.L. Lefaix, S. Delanian, and M.C. Vozenin Striking regression of subcutaneous fibrosis induced by high doses of gamma rays using a combination of pentoxifylline and alpha-tocopherol: an experimental study Int J Radiat Oncol Biol Phys 43 1999 839 847
10. M.W. Dion, D.H. Hussey, and J.F. Doornbos Preliminary results of a pilot study of pentoxifylline in the treatment of late radiation soft tissue necrosis Int J Radiat Oncol Biol Phys 19 1990 401 407
11. S. Delanian, R. Porcher, and J. Rudant Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis J Clin Oncol 23 2005 8570 8579
12. S. Delanian, C. Chatel, and R. Porcher Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial Int J Radiat Oncol Biol Phys 80 2011 832 839
13. A. Ward, and S.P. Clissold Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy Drugs 34 1987 50 97
14. B. Berman, and M.R. Duncan Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin Br J Dermatol 123 1990 339 346
15. L. Packer, S.U. Weber, and G. Rimbach Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling J Nutr 131 2001 369S 373S
16. S. Delanian, S. Balla-Mekias, and J.L. Lefaix Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol J Clin Oncol 17 1999 3283 3290
17. A.G. Wernicke, R. Rosenblatt, and M. Rasca Quantitative assessment of radiation-induced fibrosis of the breast with tissue compliance meter, palpation, and radiological imaging: preliminary results Breast J 15 2009 583 592